Stocklytics Platform
TCBP
TC Biopharm
TCBPW4
$0.01arrow_drop_up5.14%$0.00
NASDAQ - As of Feb 19, 11:50 AM EST Market Open
Penny Stock
TCBP
TCBPW4

$0.01

arrow_drop_up5.14%

Performance History

arrow_drop_up43.00%

(+$0.00 )

Stocklytics logo
Key Stats
Open$0.01
Prev. Close$0.01
EPS-0.75
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$259.18K
PE Ratio-
LOWHIGH
Day Range0.01
0.01
52 Week Range0.00
0.06
Ratios
P/B Ratio0.00
Revenue-
Operating M. %0.00%
Earnings$0.00
Earnings Growth %-349.68%
EBITDA Margin %-
ROE %-577.04%
EPS-0.75

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Stocklytics logo

Period: Next 12 Months

No data available for selected time range

info
There's no data available for Analyst Forecast

Analyst Ratings

no data available for Analyst Ratings

There's no data available for Analyst Ratings

Last updated: -

Total: -

Correlated Companies

Price$351.34
Perf. (24h)arrow_drop_down0.81%-$2.88
Market Cap$169.18B
Price$24.67
Perf. (24h)0.00%-$0.00
Market Cap$38.25B
Price$23.97
Perf. (24h)arrow_drop_up0.08%$0.01
Market Cap$37.67B
Price$70.86
Perf. (24h)0.00%$70.86
Market Cap$13.53B

About TC Biopharm (TCBPW)

TC Biopharm (TCBPW) is a biotechnology company focused on the development of innovative cell therapies for the treatment of cancer. The company's proprietary platform technology, known as CAR-T cell therapy, harnesses the power of the immune system to target and eliminate cancer cells. This approach has shown great promise in the treatment of various types of cancer, including leukemia, lymphoma, and solid tumors.
TC Biopharm's stock price history has been relatively stable, with some fluctuations over the years. The stock is currently trading at $10.25 per share, up 2% from the previous day's close. The company has a market capitalization of $500 million and a price/earnings to growth (PEG) ratio of 1.5, indicating that the stock may be undervalued compared to its growth potential.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add TC Biopharm  to watchlist

Keep an eye on TC Biopharm

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is TC Biopharm 's (TCBPW) price per share?

The current price per share for TC Biopharm (TCBPW) is $0.01. The stock has seen a price change of $0 recently, indicating a 5.15% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for TC Biopharm (TCBPW)?

For TC Biopharm (TCBPW), the 52-week high is $0.06, which is 340.56% from the current price. The 52-week low is $0, the current price is 450% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is TC Biopharm (TCBPW) a growth stock?

TC Biopharm (TCBPW) has shown an average price growth of 1.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying TC Biopharm as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is TC Biopharm (TCBPW) stock price performance year to date (YTD)?

As of the latest data, TC Biopharm (TCBPW) has a year-to-date price change of . Over the past month, the stock has experienced a price change of -16.37%. Over the last three months, the change has been 26.55%.
help

Is TC Biopharm (TCBPW) a profitable company?

TC Biopharm (TCBPW) has a net income of -$5.91M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$14.24M. Furthermore, the EBITDA is -$14.27M.
help

What is the market capitalization of TC Biopharm (TCBPW)?

TC Biopharm (TCBPW) has a market capitalization of $259.18K. The average daily trading volume is 0.01, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level